The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia

William J. Burke, Vijay Dewan, Steven Phillip Wengel, William H. Roccaforte, Grace C. Nadolny, David G. Folks

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

This retrospective chart review examines the impact of selective serotonin reuptake inhibitors on 20 patients with both depression and psychosis complicating dementia of the Alzheimer type (DAT) and other dementias. Fifteen of the 20 patients had moderate to marked improvement in depressive and psychotic symptoms. Eleven of 12 patients with DAT had moderate to marked improvement compared to only four of eight patients with dementia from other causes. The drugs were effective in diminishing or eliminating psychotic symptoms in six patients who had previously not responded to a trial of a neuroleptic. The selective serotonin reuptake inhibitors may have an important role to play in patients with DAT who have coexisting depression and psychosis. These drugs are very well tolerated and may have a place as first-line agents in non-emergent settings where a clinician might otherwise think of instituting a neuroleptic or as a second-line agent when a neuroleptic has proven ineffective.

Original languageEnglish (US)
Pages (from-to)519-525
Number of pages7
JournalInternational Journal of Geriatric Psychiatry
Volume12
Issue number5
DOIs
StatePublished - May 1 1997

Fingerprint

Serotonin Uptake Inhibitors
Psychotic Disorders
Dementia
Depression
Antipsychotic Agents
Alzheimer Disease
Pharmaceutical Preparations

Keywords

  • Dementia
  • Depression
  • Selective serotonin reuptake inhibitors

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia. / Burke, William J.; Dewan, Vijay; Wengel, Steven Phillip; Roccaforte, William H.; Nadolny, Grace C.; Folks, David G.

In: International Journal of Geriatric Psychiatry, Vol. 12, No. 5, 01.05.1997, p. 519-525.

Research output: Contribution to journalArticle

Burke, William J. ; Dewan, Vijay ; Wengel, Steven Phillip ; Roccaforte, William H. ; Nadolny, Grace C. ; Folks, David G. / The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia. In: International Journal of Geriatric Psychiatry. 1997 ; Vol. 12, No. 5. pp. 519-525.
@article{b823f7e522a6471bb32a7b871203a050,
title = "The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia",
abstract = "This retrospective chart review examines the impact of selective serotonin reuptake inhibitors on 20 patients with both depression and psychosis complicating dementia of the Alzheimer type (DAT) and other dementias. Fifteen of the 20 patients had moderate to marked improvement in depressive and psychotic symptoms. Eleven of 12 patients with DAT had moderate to marked improvement compared to only four of eight patients with dementia from other causes. The drugs were effective in diminishing or eliminating psychotic symptoms in six patients who had previously not responded to a trial of a neuroleptic. The selective serotonin reuptake inhibitors may have an important role to play in patients with DAT who have coexisting depression and psychosis. These drugs are very well tolerated and may have a place as first-line agents in non-emergent settings where a clinician might otherwise think of instituting a neuroleptic or as a second-line agent when a neuroleptic has proven ineffective.",
keywords = "Dementia, Depression, Selective serotonin reuptake inhibitors",
author = "Burke, {William J.} and Vijay Dewan and Wengel, {Steven Phillip} and Roccaforte, {William H.} and Nadolny, {Grace C.} and Folks, {David G.}",
year = "1997",
month = "5",
day = "1",
doi = "10.1002/(SICI)1099-1166(199705)12:5<519::AID-GPS534>3.0.CO;2-Q",
language = "English (US)",
volume = "12",
pages = "519--525",
journal = "International Journal of Geriatric Psychiatry",
issn = "0885-6230",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia

AU - Burke, William J.

AU - Dewan, Vijay

AU - Wengel, Steven Phillip

AU - Roccaforte, William H.

AU - Nadolny, Grace C.

AU - Folks, David G.

PY - 1997/5/1

Y1 - 1997/5/1

N2 - This retrospective chart review examines the impact of selective serotonin reuptake inhibitors on 20 patients with both depression and psychosis complicating dementia of the Alzheimer type (DAT) and other dementias. Fifteen of the 20 patients had moderate to marked improvement in depressive and psychotic symptoms. Eleven of 12 patients with DAT had moderate to marked improvement compared to only four of eight patients with dementia from other causes. The drugs were effective in diminishing or eliminating psychotic symptoms in six patients who had previously not responded to a trial of a neuroleptic. The selective serotonin reuptake inhibitors may have an important role to play in patients with DAT who have coexisting depression and psychosis. These drugs are very well tolerated and may have a place as first-line agents in non-emergent settings where a clinician might otherwise think of instituting a neuroleptic or as a second-line agent when a neuroleptic has proven ineffective.

AB - This retrospective chart review examines the impact of selective serotonin reuptake inhibitors on 20 patients with both depression and psychosis complicating dementia of the Alzheimer type (DAT) and other dementias. Fifteen of the 20 patients had moderate to marked improvement in depressive and psychotic symptoms. Eleven of 12 patients with DAT had moderate to marked improvement compared to only four of eight patients with dementia from other causes. The drugs were effective in diminishing or eliminating psychotic symptoms in six patients who had previously not responded to a trial of a neuroleptic. The selective serotonin reuptake inhibitors may have an important role to play in patients with DAT who have coexisting depression and psychosis. These drugs are very well tolerated and may have a place as first-line agents in non-emergent settings where a clinician might otherwise think of instituting a neuroleptic or as a second-line agent when a neuroleptic has proven ineffective.

KW - Dementia

KW - Depression

KW - Selective serotonin reuptake inhibitors

UR - http://www.scopus.com/inward/record.url?scp=0030965338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030965338&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1099-1166(199705)12:5<519::AID-GPS534>3.0.CO;2-Q

DO - 10.1002/(SICI)1099-1166(199705)12:5<519::AID-GPS534>3.0.CO;2-Q

M3 - Article

VL - 12

SP - 519

EP - 525

JO - International Journal of Geriatric Psychiatry

JF - International Journal of Geriatric Psychiatry

SN - 0885-6230

IS - 5

ER -